Chemours names Matthew Conti as chief human resources officer

Published 12/06/2025, 21:38
Chemours names Matthew Conti as chief human resources officer

WILMINGTON, Del. - The Chemours Company (NYSE: CC), a $1.71 billion market cap specialty chemicals manufacturer currently trading at $11.47, has appointed Matthew Conti as Chief Human Resources Officer, effective June 2, the company announced in a press release.

Conti will lead Chemours’ global human resources organization, overseeing talent strategy, organizational development, employee engagement, and culture initiatives. He will be based at the company’s global headquarters in Wilmington, Delaware, and serve as a member of the Executive Team.

"Matthew’s appointment comes at a critical time as we continue to evolve our culture and capabilities," said Denise Dignam, President and CEO of Chemours.

Conti brings over 20 years of HR leadership experience across global manufacturing, specialty chemicals, and industrial sectors. Most recently, he served as CHRO at Vantage Specialty Chemicals. He has also held senior roles at Ingredion Corporation and Precision Castparts Corporation.

"I’m honored to join Chemours at such a pivotal moment in its journey," Conti said.

The new CHRO holds a Bachelor of Arts in Economics from Kalamazoo College and an MBA from the London Business School.

Chemours is a global provider of industrial and specialty chemicals through its three business segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. The company has approximately 6,000 employees and 28 manufacturing sites serving about 2,500 customers in approximately 110 countries.

In other recent news, Chemours Company has made several strategic moves and faced mixed analyst reactions. The company announced a new partnership with DataVolt to enhance data center efficiency using Chemours’ Opteon™ dielectric fluids, aiming to address the demands of AI and next-generation chips. Additionally, Chemours has entered into an agreement with Navin Fluorine to produce an innovative cooling fluid for data centers, set to begin in 2026. This collaboration focuses on reducing environmental impact and operational costs for advanced data centers.

On the financial side, Chemours’ first-quarter earnings per share fell short of expectations, leading Jefferies to cut its price target to $11.50 while maintaining a Hold rating. Truist Securities also revised its price target, lowering it to $20 but kept a Buy rating, citing expected earnings growth in the Titanium Dioxide segment and a return to positive free cash flow. Chemours continues to see success with its Opteon product line, maintaining high margins and progressing towards commercialization in the data center cooling market.

The company has also appointed Nathan Blom as Vice President of its liquid cooling portfolio to drive growth in this sector. These developments reflect Chemours’ ongoing efforts to innovate and adapt to market demands, particularly in the realm of sustainable solutions for data centers.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.